Creation and practice of a novel molecular evaluation technical system for human spermatozoa characteristics

Abstract Background Male infertility is a condition that is predominantly attributable to diminished spermatozoa characteristics and it presents with a wide spectrum of clinical manifestations (normozoospermia, asthenozoospermia, oligozoospermia, oligoasthenozoospermia, and necrozoospermia, teratozoospermia). The etiology underlying this condition is highly complex and heterogeneous. Currently, many clinical techniques are available to evaluate the characteristics of human spermatozoa. However, a novel technology capable of precisely detecting the molecular phenotype of human spermatozoa and enabling the etiological diagnosis of related male infertility is still lacking. Methods We established a new “molecular evaluation technology system for human spermatozoa characteristics” system (MEHS). MEHS includes the following: (1) a molecular antibody hybridization immunofluorescence assay; (2) quantitative analysis software for human spermatozoa functional molecule phenotypes in spermatozoa; and (3) a landmark atlas of the normal human spermatozoa functional molecule phenotypes. Through the analysis of 800 clinical samples exhibiting different manifestations, we judged the function and characteristics of spermatozoa. This allows the identification of male infertility target molecules caused by abnormal phenotypes (deficient, decreased, increased, shifted, or disabled) of spermatozoa functional molecules. Results We revealed that five target molecules presented abnormal phenotypes. The male infertility rates associated with different manifestations were 79.4% (the infertility rates associated with infertile normozoospermia were 44%, and that associated with oligozoospermia, oligoasthenozoospermia, and necrozoospermia was 95%). Conclusions MEHS can accurately detect the molecular phenotype in male infertility spermatozoa, identify the target molecules of male infertility, and be used for the detection of male infertility and its related causes. In addition, it can be detected that male infertility is caused by abnormal expression of one or more molecules. Accurate evaluation of spermatozoa characteristics via MEHS also assists clinicians in selecting optimal assisted reproductive technology protocols, thereby reducing unnecessary diagnostic procedures, treatment cycles, and patient costs. MEHS overcomes the limitations of the existing clinical human spermatozoa evaluation technologies and has potential scientific value and broad clinical applications.

Authors

Publication Details

Journal
European journal of medical research
Published
2026-11-14
DOI
https://doi.org/10.1186/s40001-026-05449-8
Primary Topic
Sperm and Testicular Function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Creation and practice of a novel molecular evaluation technical system for human spermatozoa characteristics

Chuanxi Fan, Kai Hong, Kun Jiang, Jie Du et al.
European journal of medical research
Sperm and Testicular Function
article

Creation and practice of a novel molecular evaluation technical system for human spermatozoa characteristics

Chuanxi Fan, Kai Hong, Kun Jiang, Jie Du, Ji Xu, Haocheng Lin, Haiyan Wang, Wenhong Lu, Hui Shi, Wenting Wang, Jie Liu, Jianyuan Li, Yunxiang Liu, Yiqun Gu, Haitao Zhang, Jianfang Zhang
article en

Abstract

Abstract Background Male infertility is a condition that is predominantly attributable to diminished spermatozoa characteristics and it presents with a wide spectrum of clinical manifestations (normozoospermia, asthenozoospermia, oligozoospermia, oligoasthenozoospermia, and necrozoospermia, teratozoospermia). The etiology underlying this condition is highly complex and heterogeneous. Currently, many clinical techniques are available to evaluate the characteristics of human spermatozoa. However, a novel technology capable of precisely detecting the molecular phenotype of human spermatozoa and enabling the etiological diagnosis of related male infertility is still lacking. Methods We established a new “molecular evaluation technology system for human spermatozoa characteristics” system (MEHS). MEHS includes the following: (1) a molecular antibody hybridization immunofluorescence assay; (2) quantitative analysis software for human spermatozoa functional molecule phenotypes in spermatozoa; and (3) a landmark atlas of the normal human spermatozoa functional molecule phenotypes. Through the analysis of 800 clinical samples exhibiting different manifestations, we judged the function and characteristics of spermatozoa. This allows the identification of male infertility target molecules caused by abnormal phenotypes (deficient, decreased, increased, shifted, or disabled) of spermatozoa functional molecules. Results We revealed that five target molecules presented abnormal phenotypes. The male infertility rates associated with different manifestations were 79.4% (the infertility rates associated with infertile normozoospermia were 44%, and that associated with oligozoospermia, oligoasthenozoospermia, and necrozoospermia was 95%). Conclusions MEHS can accurately detect the molecular phenotype in male infertility spermatozoa, identify the target molecules of male infertility, and be used for the detection of male infertility and its related causes. In addition, it can be detected that male infertility is caused by abnormal expression of one or more molecules. Accurate evaluation of spermatozoa characteristics via MEHS also assists clinicians in selecting optimal assisted reproductive technology protocols, thereby reducing unnecessary diagnostic procedures, treatment cycles, and patient costs. MEHS overcomes the limitations of the existing clinical human spermatozoa evaluation technologies and has potential scientific value and broad clinical applications.

European journal of medical research
Sperm and Testicular Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon